INFECTIOUS ECONOMICS | by Blythe Adamson
LEARNING THE ECONOMICS OF INFECTIOUS DISEASES
Here is a list of words I learned in my first 3 months after joining a trendy health tech company in Manhattan. After my past jobs in academics, non-profit, industry, and consulting, I was unprepared for the culture of communication at a tech start-up company. My new workplace was filled with mission-driven millennials, t-shirt wearing software engineers, … Continue reading Glossary for a Health Tech Company
Listen to this episode of The Full Story from NPR station WSHU, where I join the conversation for a live interview with Ron Ropiak. Skip straight to the heart of our chat, recorded minutes 29 through 43, in this lively, thought-provoking talk show. Issues in Healthcare Religious exemptions for the measles vaccine, flare-ups of sexually … Continue reading Live NPR interview
It has been a privilege to serve and represent more than 5,000 health economics graduate students in 77 countries and support the work of presidents from 107 student chapters during my term as Chair of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Student Network in 2017-2018. Where We Are Today I continue to be … Continue reading ISPOR Leadership and Legacy
Lab coats are being ironed, promo stickers wrapped around candy bars, and strangers pulled off the street to help with utility testing. It’s time for the Business Plan Competition. Continue reading Investment Round
A key to making causal inference with observational data Continue reading Propensity Scores
It is hard for us to know exactly how many people take the drug Truvada (TDF/FTC) to prevent versus treat HIV. Word is spreading through communities about this daily pill to the reduce risk of infection, and as people become informed the number of users is increasing. Can Google help us predict this uptake? Building … Continue reading Predicting Drug Uptake Using Google Searches
I met 18 Nobel Prize winners in Economics and some of the brightest economics Ph.D. students from around the world at the Lindau Nobel Laureate Meeting in Germany. We swapped ideas and inspired each other over five days of activities. After Lindau, I continued traveling to meet with leaders of health economics in Zurich, Basel, … Continue reading The Nobel Meeting
During a visit to the French Ministry of Health, Emilie Sam explained to me the mechanisms for French investments in the innovation of new biomedical technologies. Many of the new life-saving products have a big impact on their budget for medicines in France. It will be interesting to wait and see at what rate this … Continue reading French Innovation
Often the fastest graph to generate is not the simplest way to communicate meaning. For an analysis of trends over time in pharmacoeconomic graduate student interests, take a look at this figure before and then after modifications to improve visualization of survey results. The first graph under-utilizes the ordering of years by assigning color categories … Continue reading Before & After: Time Series Visualization
